The place of Omalizumab in the treatment of Carboplatin hypersensitivity

J BUON. 2021 Sep-Oct;26(5):2205.

Author

Yasemin Benderli Cihan¹

Affiliation

¹ Kayseri Education and Research Hospital, Department of Radiation Oncology, Sanayi District, Ataturk Boulevard, Hastane Street, No 78, 38010 Kocasinan, Kayseri, Turkey.

PMID: 34761641

No abstract available

Publication types

Letter

MeSH terms

Anti-Allergic Agents / therapeutic use*
Antineoplastic Agents / adverse effects*
Carboplatin / adverse effects*
Drug Hypersensitivity / drug therapy*
Drug Hypersensitivity / etiology*
Humans
Omalizumab / therapeutic use*

Substances

Anti-Allergic Agents
Antineoplastic Agents
Omalizumab
Carboplatin